Ken Fisher's position in Veracyte is currently worth $39.5M. That's 0.01% of their equity portfolio (264th largest holding). The first Veracyte trade was made in Q1 2021. Since then Ken Fisher bought shares eleven more times and sold shares on nine occasions. The stake costed the investor $25.6M, netting the investor a gain of 54% so far.